3
Applications for openfor.co/bootcamp - 2025 SPRING Cohort is OPEN, and the final application deadline is Feburary 16th, 2025 Apply Now!
Openfor.co is a global success based partnership development platform where you can find and develop partnerships.
Collab Overview
We are open for collaborations with the companies, universities and other startups in the molecular biology field. We would like expand our fast cancer diagnostic technology world wide.
Co-Brand
Blogging, social media influencer, content
Co-Develop
New products, services, and PoC
Co-Sell
Affiliate, bundle, resale, distribution partnerships
Co-Supply
Supplier & procurement partnerships
Co-Cause
Support a common cause together
About Us
OaCP , Oncology and Cytogenetic Products is an bio tech company from Italy who reduces the diagnostic time of cancer. OaCP provides CE approved and proprietary advanced diagnostic reagents that make 50% less costly and 97% faster DNA tests for cancer diagnosis using In Situ Hybridization. OaCP products also allow easier and faster RT PCR tests for Viral (eg. COVID-19), Microbiological and Cancer analysis. "Our objective is to provide oncology diagnostics laboratories and research institutions with fast FISH solutions that will disrupt cancer diagnosis times and costs. OaCP (oncology-and-cytogenetic-products) reduces cancer’ genetic tests time from 3 days to 2 hours and the cost by 50% with its chemical reagents.
Industry:
BioTechnology
Team Size:
11-50
Headquarter:
Ireland
Founded:
2017
Highlights
$330 K total funding amount
The global FIRST CE-IVD COVID-19 Nucleic Acid Detection Kit that simultaneously detect COVID-19 positivity and the presence of its main variants
14 awards for the efforts in molecular biology and in fast laboratory diagnostics.
2 Sales representatives in Italy and Japan
17 countries distribution network
Team of professionals with 50+ years of experience combined
